Start-Up Raises $200 Million to Speed Up Drug Trials

Start-Up Raises $200 Million to Speed Up Drug Trials

The New York Times - Business:

New York-based Paradigm has raised a significant amount to simplify clinical trials. Its goal is ambitious, but its challenges are many, researchers say.

This post first appeared in The New York Times - Business. Read the original article.